Grantham, Mayo, Van Otterloo & Co (GMO)’s iShares MSCI Emerging Markets ex China ETF EMXC Stock Holding History
Bought
Maintained
Sold
Other funds holding EMXC
CFB
Grantham, Mayo, Van Otterloo & Co (GMO)'s EMXC Position: Q2 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) increased its iShares MSCI Emerging Markets ex China ETF (EMXC) stake by 10% in Q2 2026, buying an estimated $107K and bringing the position to 11,947 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #497.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in EMXC in Q3 2024 and has held it in 5 quarters since. The position peaked at $6.13M in Q3 2024. 1,021 funds tracked by Wall St. Rank hold EMXC as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 11,947 shares of iShares MSCI Emerging Markets ex China ETF worth $1.22M as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) bought 1,130 iShares MSCI Emerging Markets ex China ETF shares in Q2 2026, an estimated $107K.
- iShares MSCI Emerging Markets ex China ETF made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #497 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in iShares MSCI Emerging Markets ex China ETF in Q3 2024 and has held it in 5 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s iShares MSCI Emerging Markets ex China ETF position peaked at $6.13M in Q3 2024.
- 1,021 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ex China ETF as of Q2 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.